The purposes of this study are to determine the maximum tolerated dose of carboplatin in conjunction with thymidine, to determine clinical toxicity of thymidine and/or carboplatin, to compare the combination to carboplatin alone, to assess pharmacokinetics of both agents, and to assess antineoplastic effects.
Showing the most recent 10 out of 459 publications